This federal contract indefinite delivery vehicle (IDV) award by the Food and Drug Administration (FDA), a civilian agency, is a single-award contract with Digim Solution LLC, a minority-owned and for-profit small business. The $5,000,500 IDV contract has a period of performance ending June 20, 2029 and is for 3D microscopy, artificial intelligence-based quantification, and modeling to support non-clinical evaluation and regulatory activities for complex drug products.
Under this IDV, a $360,000 firm fixed price task order has been awarded to Digim Solution for 3D microscopy, AI-based quantification, and modeling to evaluate the quality attributes and critical performance of complex injectable and insertable drug products. This task order, which does not have a set-aside designation, has a period of performance ending March 9, 2026 and will be performed in Woburn, MA. The contracted work is intended to provide the FDA with advanced product characterization, artificial intelligence analysis, and microstructure evaluation capabilities to support their regulatory responsibilities for these types of complex drug products.
Generated 12/5/24, 9:07 AM